FSTX - F-star Therapeutics GAAP EPS of -$0.57 beats by $0.11 revenue of $2.55M beats by $0.99M May, 10 2022 08:02 AM F-star Therapeutics Inc Com F-star Therapeutics press release (NASDAQ:FSTX): Q1 GAAP EPS of -$0.57 beats by $0.11. Revenue of $2.55M (-12.7% Y/Y) beats by $0.99M. For further details see: F-star Therapeutics GAAP EPS of -$0.57 beats by $0.11, revenue of $2.55M beats by $0.99M